Hepatocellular Carcinoma Drugs (PD-1/PD-L1 Inhibitors, Tyrosine Kinase Inhibitors) Industry Report 2024: A $1.62 Billion Market Opportunity by 2028
January 24, 2024 13:42 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global hepatocellular...
Hepatocellular Carcinoma Clinical Trial Analysis: DelveInsight Evaluates a Robust Pipeline as 90+ Influential Pharma Players to Set Foot in the Domain
June 26, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, June 26, 2023 (GLOBE NEWSWIRE) -- Hepatocellular Carcinoma Clinical Trial Analysis: DelveInsight Evaluates a Robust Pipeline as 90+ Influential Pharma Players to Set Foot in the...
Hepatocellular Carcinoma Drugs Market is Forecasted to Reach Nearly USD 1.95 Billion by 2030, Size, Share, Trends, Competitive Scenario and Regional Analysis
January 11, 2023 21:30 ET
|
Data Bridge Market Research
SYDNEY, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research Published Latest Hepatocellular Carcinoma Drugs Market Study with an in-depth analysis of the current scenario, the Market size,...